Pages that link to "Q67674926"
Jump to navigation
Jump to search
The following pages link to Prostate Specific Antigen for Assessing Response to Ketoconazole and Prednisone in Patients with Hormone Refractory Metastatic Prostate Cancer (Q67674926):
Displaying 11 items.
- Current strategies in the management of hormone refractory prostate cancer (Q35145701) (← links)
- Hormone Refractory Prostatic Cancer: The Role of Radiolabelled Diphosphonates and Growth Factor Inhibitors (Q35166528) (← links)
- Systemic therapy of prostate cancer. new concepts from prostate cancer tumor biology (Q40488406) (← links)
- Estramustine and vinblastine for patients with progressive androgen-independent adenocarcinoma of the prostate (Q40682505) (← links)
- Post-therapy change in prostate-specific antigen levels as a clinical trial endpoint in hormone-refractory prostatic cancer: a trial with 10-ethyl-deaza-aminopterin (Q41025718) (← links)
- Ketoconazole-induced adrenal crisis in a patient with metastatic prostatic adenocarcinoma: case report and review of the literature (Q41466363) (← links)
- Therapy for hormone-resistant prostate cancer: no longer a myth (Q41547284) (← links)
- Surrogate endpoints (Q42390152) (← links)
- Phase II Study of Estramustine, Oral Etoposide, and Vinorelbine in Hormone-Refractory Prostate Cancer (Q42548235) (← links)
- Editorial: Hormone refractory metastatic prostate cancer (Q68181421) (← links)
- Absence of antitumor activity with prednisone in patients with progressive androgen-independent prostate carcinoma (Q83169227) (← links)